PRNP and chronic kidney disease: These findings suggest that TUDCA-treated MSCs could be a strong candidate for autologous stem cell-based therapeutics for CKD, and that PrPC might be a key molecule for protection against ROS-associated ER stress in the hippocampus of CKD patients.